News Sentiment

OBIO sentiment intelligence

Orchestra BioMed Holdings Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 55 Balanced news tone 54 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 3.99 Week of 10 Jul 2026
Weighted tone 55/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

81/100 classification confidence.

Company focus 46

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-4.8% over one week, -2.7% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Price to earnings forward of Orchestra BioMed Holdings, Inc. – BOATS:OBIO

Market Reaction

Price moving ahead of tone

64/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 81/100 classification
One-week reaction -4.8% Price reacting lower
Trend fit Trend inactive -2.7% over four weeks
Fair value -20.9% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 15
Neutral 33
Negative 6

Relevance

Why the article matched

Direct first
Direct company coverage 46
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 9
Market source 7
GlobeNewswire 6
TradingView 4
Investing.com 3
TradingKey 3
www.marketscreener.com 2
Investing.com Nigeria 2

Event Lens

What the news is about

Classified themes
Market update 31
Earnings 17
Analyst action 4
Macro sensitivity 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 54
TradingView Direct company coverage

Price to earnings forward of Orchestra BioMed Holdings, Inc. – BOATS:OBIO

This article provides financial information for Orchestra BioMed Holdings, Inc. (OBIO), specifically focusing on its "Price to earnings forward" metric. The content indicates that the market was closed with no trades recorded at the time of the data.

Tone
Neutral 50/100
Event
Earnings
Published
11 Jul 2026 19:41
Source
TradingView
Finviz Direct company coverage

OBIO - Orchestra BioMed Holdings Inc Latest SEC Filings

This article provides the latest SEC filings and comprehensive financial data for Orchestra BioMed Holdings Inc. (OBIO). It details the company's stock performance, key financial metrics, insider and institutional ownership, and analyst recommendations, offering a snapshot of its

Tone
Neutral 50/100
Event
Analyst action
Published
06 Jul 2026 06:11
Source
Finviz
Stock Titan Direct company coverage

Orchestra BioMed (OBIO) insider sells 15,000 shares under 10b5-1 plan

Darren Sherman, a director and officer of Orchestra BioMed Holdings (OBIO), sold 15,000 shares of common stock at a weighted average price of $4.27 per share. This transaction, executed under a pre-established Rule 10b5-1 trading plan adopted on December 18, 2025, involved sales

Tone
Negative 40/100
Event
Market update
Published
02 Jul 2026 20:40
Source
Stock Titan
Stock Titan Direct company coverage

Darren Sherman to sell 15,000 OBIO shares (NASDAQ: OBIO)

Darren Sherman has filed a Form 144 indicating an intent to sell 15,000 shares of Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO) common stock, with a proposed sale date of June 1, 2026, and a reported gross amount of $58,049.53. The filing also details prior restricted stock vest

Tone
Neutral 50/100
Event
Market update
Published
01 Jul 2026 15:45
Source
Stock Titan
Simply Wall Street Direct company coverage

Orchestra BioMed Holdings' Market Cap Up US$40m Following Year Of Insider Stock Buying

Orchestra BioMed Holdings (NASDAQ:OBIO) saw its market capitalization increase by US$40 million after a 16% stock rise, rewarding insiders who bought shares over the past year with a 36% gain. Insiders purchased US$321.7k worth of stock, now valued at US$438.9k, with the biggest

Tone
Positive 67/100
Event
Market update
Published
30 Jun 2026 11:39
Source
Simply Wall Street
Moomoo Direct company coverage

Orchestra BioMed Joins Russell 3000 and Russell 2000 Indexes

Orchestra BioMed Holdings, Inc. has been added to the Russell 3000 and Russell 2000 Indexes, effective July 1, 2026, as part of the annual reconstitution. This inclusion is expected to increase the company's visibility within the investment community. The Russell indexes are wide

Tone
Positive 71/100
Event
Market update
Published
30 Jun 2026 05:09
Source
Moomoo
www.marketscreener.com Direct company coverage

Orchestra BioMed Holdings, Inc.(NasdaqGM: OBIO) added to Russell 2000 Index

Orchestra BioMed Holdings, Inc. (NasdaqGM: OBIO) has been added to the Russell 2000 Index. This inclusion is a significant development for the biomedical innovation company, which specializes in therapies for hypertension and atherosclerotic artery disease. The article also provi

Tone
Positive 71/100
Event
Market update
Published
29 Jun 2026 17:48
Source
www.marketscreener.com
Investing.com Direct company coverage

Orchestra BioMed joins Russell 2000 and 3000 indexes

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) has been added to the Russell 3000 and Russell 2000 indexes as part of the 2026 annual reconstitution. This inclusion, effective after the U.S. market close on Friday, means the company, with a $254 million market capitalization and 5

Tone
Positive 73/100
Event
Market update
Published
29 Jun 2026 12:13
Source
Investing.com
Market source Direct company coverage

Orchestra BioMed Joins Russell 3000® and Russell 2000® Indexes

Orchestra BioMed Holdings, Inc. announced its inclusion in the Russell 3000® Index and Russell 2000® Index, effective June 26, 2026, following the annual reconstitution of Russell indexes. This membership means automatic inclusion in various growth and value style indexes, signal

Tone
Positive 74/100
Event
Market update
Published
29 Jun 2026 12:13
Source
Market source
Stock Titan Direct company coverage

Orchestra BioMed lands in Russell indexes tracking $12.2T

Orchestra BioMed (NASDAQ: OBIO) has announced its inclusion in the broad-market Russell 3000® Index and the small-cap Russell 2000® Index, effective June 26, 2026, after the U.S. market close. This membership provides automatic inclusion in related growth and value indexes, as Ru

Tone
Positive 73/100
Event
Market update
Published
29 Jun 2026 12:13
Source
Stock Titan
www.marketscreener.com Direct company coverage

Orchestra BioMed Holdings, Inc.(NasdaqGM:OBIO) added to Russell 2000 Growth Benchmark

Orchestra BioMed Holdings, Inc. (NasdaqGM:OBIO) has been added to the Russell 2000 Growth Benchmark. The company specializes in biomedical innovation with lead product candidates including Atrioventricular Interval Modulation (AVIM) therapy for hypertension and Virtue Sirolimus A

Tone
Positive 72/100
Event
Market update
Published
29 Jun 2026 11:13
Source
www.marketscreener.com
TradingView Direct company coverage

Orchestra BioMed Holdings, Inc. Actuals & Estimates (NASDAQ:OBIO)

This article provides financial actuals and estimates for Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO), detailing its stock performance, analyst forecasts, earnings, revenue, and other key financial metrics. It includes frequently asked questions about OBIO's stock price, market

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 04:39
Source
TradingView
TradingView Direct company coverage

OBIO Forecast — Price Target — Prediction for 2027

The article provides a forecast for Orchestra BioMed Holdings, Inc. (OBIO) stock, including analyst price targets, historical performance, and financial data. Analysts have a maximum price target of $20.00 and a minimum of $9.00 for OBIO. The company's stock has shown recent gain

Tone
Positive 67/100
Event
Analyst action
Published
26 Jun 2026 01:40
Source
TradingView
Investing.com Nigeria Direct company coverage

Form 4 Orchestra Biomed Holdings Inc For: 25 June By Investing.com

This article provides a Form 4 filing for Orchestra Biomed Holdings Inc. for June 25, indicating potential insider trading activity. It lists the stock symbol OBIO and mentions a modest price increase for the company, alongside various market indices and commodity prices.

Tone
Neutral 50/100
Event
Macro sensitivity
Published
26 Jun 2026 00:39
Source
Investing.com Nigeria
Stock Titan Direct company coverage

Orchestra BioMed (NASDAQ: OBIO) director receives new RSU and stock option grants

Orchestra BioMed Holdings, Inc. director Pamela Ann Connealy received 17,327 restricted stock units (RSUs) and stock options for 21,277 shares, as compensation. The RSUs and stock options were granted on June 23, 2026, with an exercise price of $4.0400 per share, and both will ve

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 20:11
Source
Stock Titan
Stock Titan Direct company coverage

Orchestra BioMed (OBIO) director granted RSUs, shares withheld for taxes

Orchestra BioMed Holdings, Inc. director John Prosper Mack received an award of 34,653 Restricted Stock Units (RSUs) on June 23, 2026, which will vest after one year of continuous service. Concurrently, 3,510 shares were withheld from previously vested RSUs to cover tax obligatio

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 20:11
Source
Stock Titan
Stock Titan Direct company coverage

Orchestra BioMed (OBIO) director logs RSU tax withholding and 42,553-option grant

Orchestra BioMed Holdings director Chris Cleary reported compensation-related equity transactions, including the disposal of 3,510 common shares for tax obligations tied to restricted stock units (RSUs) vesting. He also received a grant of stock options for 42,553 shares at an ex

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 20:11
Source
Stock Titan
Stock Titan Direct company coverage

Orchestra BioMed (OBIO) director receives 42,553 stock options at $4.04 strike

Orchestra BioMed Holdings director Aryeh Jason was granted 42,553 stock options at an exercise price of $4.04 per share. These options, which have no upfront cash payment, will vest on the one-year anniversary of the June 23, 2026 grant date, provided Jason continues his service

Tone
Neutral 50/100
Event
Balance sheet
Published
25 Jun 2026 20:11
Source
Stock Titan
Stock Titan Direct company coverage

Orchestra BioMed (OBIO) director awarded RSUs, options and tax shares withheld

Orchestra BioMed Holdings director Eric S. Fain, through the Fain Living Trust, received grants of 17,327 restricted stock units (RSUs) and 21,277 stock options on June 23, 2026, with an exercise price of $4.04 per share, both vesting after one year of continuous service. On June

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 20:11
Source
Stock Titan
Investing.com Direct company coverage

Orchestra BioMed shareholders approve director elections and key proposals at annual meeting

Orchestra BioMed Holdings, Inc. shareholders approved all five proposals at their 2026 Annual Meeting, including the election of three Class III directors, the ratification of Ernst & Young LLP as their accounting firm, and the adoption of the 2026 Employee Stock Purchase Plan. S

Tone
Positive 62/100
Event
Market update
Published
24 Jun 2026 00:40
Source
Investing.com
Investing.com Nigeria Direct company coverage

Form 8K Orchestra Biomed Holdings Inc For: 23 June By Investing.com

This article reports on the filing of a Form 8K by Orchestra Biomed Holdings Inc. for June 23, 2026. It notes that Orchestra Biomed Holdings Inc. (OBIO) saw an 8.72% increase. The article provides the title, author, and publication timestamp.

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 22:04
Source
Investing.com Nigeria
Stock Titan Direct company coverage

Orchestra BioMed (NASDAQ: OBIO) investors approve all 2026 meeting items

Orchestra BioMed Holdings, Inc. announced the results of its 2026 Annual Meeting of Stockholders, where five proposals were acted upon. Shareholders elected three Class III directors, ratified Ernst & Young LLP as the independent auditor for 2026, and approved the 2026 equity inc

Tone
Neutral 50/100
Event
Earnings
Published
23 Jun 2026 20:39
Source
Stock Titan
The Globe and Mail Direct company coverage

Orchestra BioMed Holdings (OBIO) Gets a Hold from BTIG

BTIG analyst maintained a Hold rating on Orchestra BioMed Holdings (OBIO) on June 15, with the company's shares closing at $3.97. Despite a strong buy consensus with an average price target of $11.40, Orchestra BioMed reported a Q1 revenue of $110 thousand and a GAAP net loss of

Tone
Neutral 50/100
Event
Analyst action
Published
19 Jun 2026 23:10
Source
The Globe and Mail
TradingKey Direct company coverage

Orchestra Biomed Holdings Inc (OBIO) Institutional Confidence

Orchestra Biomed Holdings Inc (OBIO) currently has an institutional shareholding score of 3.00, placing it 132nd out of 204 in the Healthcare Equipment & Supplies industry. The institutional shareholding proportion is 42.19%, reflecting a 7.86% increase quarter-over-quarter. Stev

Tone
Positive 60/100
Event
Market update
Published
18 Jun 2026 09:39
Source
TradingKey